» Articles » PMID: 32723699

Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCT

Overview
Date 2020 Jul 30
PMID 32723699
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The rule of 5 is a simple rule for detecting retinal nerve fiber layer (RNFL) change on spectral-domain OCT (SD-OCT), in which a loss of 5 μm of global RNFL on a follow-up test is considered evidence of significant change when compared with the baseline. The rule is based on short-term test-retest variability of SD-OCT and is often used in clinical practice. The purpose of this study was to compare the rule of 5 with trend-based analysis of global RNFL thickness over time for detecting glaucomatous progression.

Design: Prospective cohort.

Participants: A total of 300 eyes of 210 glaucoma subjects followed for an average of 5.4±1.5 years with a median of 11 (interquartile range, 7-14) visits.

Methods: Trend-based analysis was performed by ordinary least-squares (OLS) linear regression of global RNFL thickness over time. For estimation of specificity, false-positives were obtained by assessing for progression on series of randomly permutated follow-up visits for each eye, which removes any systematic trend over time. The specificity of trend-based analysis was matched to that of the rule of 5 to allow meaningful comparison of the "hit rate," or the proportion of glaucoma eyes categorized as progressing at each time point, using the original sequence of visits.

Main Outcome Measures: Comparison between hit rates of trend-analysis versus rule of 5 at matched specificity.

Results: After 5 years, the simple rule of 5 identified 37.5% of eyes as progressing at a specificity of 81.1%. At the same specificity, the hit rate for trend-based analysis was significantly greater than that of the rule of 5 (62.9% vs. 37.5%; P < 0.001). If the rule of 5 was required to be repeatable on a consecutive test, specificity improved to 93.4%, but hit rate decreased to 21.0%. At this higher specificity, trend-based analysis still had a significantly greater hit rate than the rule of 5 (47.4% vs. 21.0%, respectively; P < 0.001).

Conclusions: Trend-based analysis was superior to the simple rule of 5 for identifying progression in glaucoma eyes and should be preferred as a method for longitudinal assessment of global SD-OCT RNFL change over time.

Citing Articles

A SPATIALLY VARYING HIERARCHICAL RANDOM EFFECTS MODEL FOR LONGITUDINAL MACULAR STRUCTURAL DATA IN GLAUCOMA PATIENTS.

Su B, Weiss R, Nouri-Mahdavi K, Holbrook A Ann Appl Stat. 2025; 18(4):3444-3466.

PMID: 40017564 PMC: 11864210. DOI: 10.1214/24-aoas1944.


Deep learning and optical coherence tomography in glaucoma: Bridging the diagnostic gap on structural imaging.

Thompson A, Falconi A, Sappington R Front Ophthalmol (Lausanne). 2024; 2:937205.

PMID: 38983522 PMC: 11182271. DOI: 10.3389/fopht.2022.937205.


Clinical risk stratification in glaucoma.

Poostchi A, Kastner A, Konstantakopoulou E, Gazzard G, Jayaram H Eye (Lond). 2023; 37(15):3121-3127.

PMID: 36918628 PMC: 10013986. DOI: 10.1038/s41433-023-02480-5.


Prediction of visual field defects from macular optical coherence tomography in glaucoma using cluster analysis.

Tong J, Alonso-Caneiro D, Kalloniatis M, Zangerl B Ophthalmic Physiol Opt. 2022; 42(5):948-964.

PMID: 35598146 PMC: 9544890. DOI: 10.1111/opo.12997.

References
1.
Leung C, Yu M, Weinreb R, Ye C, Liu S, Lai G . Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a prospective analysis of age-related loss. Ophthalmology. 2012; 119(4):731-7. DOI: 10.1016/j.ophtha.2011.10.010. View

2.
OLeary N, Chauhan B, Artes P . Visual field progression in glaucoma: estimating the overall significance of deterioration with permutation analyses of pointwise linear regression (PoPLR). Invest Ophthalmol Vis Sci. 2012; 53(11):6776-84. DOI: 10.1167/iovs.12-10049. View

3.
Urata C, Mariottoni E, Jammal A, Ogata N, Thompson A, Berchuck S . Comparison of Short- And Long-Term Variability in Standard Perimetry and Spectral Domain Optical Coherence Tomography in Glaucoma. Am J Ophthalmol. 2019; 210:19-25. PMC: 7224685. DOI: 10.1016/j.ajo.2019.10.034. View

4.
Wu Z, Medeiros F, Weinreb R, Zangwill L . Performance of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma. Am J Ophthalmol. 2018; 196:10-17. PMC: 6258276. DOI: 10.1016/j.ajo.2018.08.010. View

5.
Odberg T, Jakobsen J, Hultgren S, Halseide R . The impact of glaucoma on the quality of life of patients in Norway. I. Results from a self-administered questionnaire. Acta Ophthalmol Scand. 2001; 79(2):116-20. DOI: 10.1034/j.1600-0420.2001.079002116.x. View